SCHEMBL179694

SCHEMBL179694

COc1cc2cc3c4cc(-c5ccccc5)c(OC)cc4cc[n+]3c(C)c2cc1OC

nearest known ligand 0.74

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.74
HPGD P15428 3/20 0.74
KDM4E B2RXH2 3/20 0.74
ALDH1A1 P00352 3/20 0.74
CASP1 P29466 2/20 0.74
CASP7 P55210 2/20 0.74
HSD17B10 Q99714 2/20 0.74
MAPT P10636 2/20 0.74
MEN1 O00255 1/20 0.74
MAPK1 P28482 1/20 0.74
KMT2A Q03164 1/20 0.74
ACACA Q13085 1/20 0.39
PGR P06401 1/20 0.37
RAC1 P63000 3/20 0.36
CDC42 P60953 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
WHR1 P49842 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL128708 0.93 KDM4E (0.63) CYP3A4HPGDKDM4EALDH1A1CASP1
SCHEMBL13076467 0.90 KDM4E (0.74) CYP3A4HPGDKDM4EALDH1A1CASP1
SCHEMBL13076482 0.89 KDM4E (0.72) CYP3A4HPGDKDM4EALDH1A1CASP1
SCHEMBL128843 0.89 HPGD (0.58) CYP3A4HPGDKDM4EALDH1A1CASP1
SCHEMBL13076896 0.88 CYP3A4 (0.74) CYP3A4HPGDKDM4EALDH1A1CASP1
SCHEMBL278878 0.87 KDM4E (0.97) CYP3A4HPGDKDM4EALDH1A1CASP1
SCHEMBL13076465 0.87 CYP3A4 (0.65) CYP3A4HPGDKDM4EALDH1A1CASP1
SCHEMBL195341 0.86 CYP3A4 (0.63) CYP3A4HPGDKDM4EALDH1A1CASP1
Hydrochloric Acid SCHEMBL3320097 0.86 KDM4E (1.00) CYP3A4HPGDKDM4EALDH1A1CASP1
SCHEMBL192425 0.85 CYP3A4 (0.68) CYP3A4HPGDKDM4EALDH1A1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9227966-B2 Antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-01-05 US disclosed
US-20140315939-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-10-23 US disclosed
US-20120059026-A1 ANTIMICROBIAL AGENTS UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2012-03-08 US disclosed
WO-2010127307-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059026-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L CYP3A4 464/4885HPGD 4046/4885KDM4E 2001/4885
US-20140315939-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L CYP3A4 629/4885HPGD 4224/4885KDM4E 1992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.